Niravoline

From WikiMD's WELLNESSPEDIA

Chemical structure of Niravoline

Niravoline is a chemical compound that acts as a selective kappa-opioid receptor agonist. It has been studied for its potential therapeutic effects, particularly in the context of renal function and water retention.

Chemical Properties[edit]

Niravoline is characterized by its specific interaction with the kappa-opioid receptors, which are one of the three main classes of opioid receptors, the others being mu and delta receptors. The chemical structure of Niravoline allows it to selectively bind to these receptors, influencing various physiological processes.

Mechanism of Action[edit]

Niravoline exerts its effects primarily through the activation of kappa-opioid receptors. These receptors are G-protein coupled receptors that, when activated, can modulate neurotransmitter release and influence pain perception, mood, and diuresis. The activation of kappa-opioid receptors by Niravoline has been shown to have diuretic effects, making it a compound of interest in the study of edema and hypertension.

Therapeutic Applications[edit]

Research into Niravoline has focused on its potential use in treating conditions related to water retention and renal function. Its diuretic properties suggest it could be beneficial in managing conditions such as congestive heart failure and cirrhosis, where fluid retention is a significant concern. Additionally, its effects on mood and perception have led to investigations into its potential use in psychiatry, particularly for conditions involving dysphoria and stress.

Side Effects[edit]

As with many compounds that interact with the opioid system, Niravoline may have side effects. These can include alterations in mood, perception, and potential dysphoric effects due to its action on kappa-opioid receptors. However, its selective action reduces the risk of some side effects commonly associated with non-selective opioid receptor agonists.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.